NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

8718	Companies
152860	Keywords
88458	Articles
82163	Press releases

Home
Companies
NanoViricides, Inc.

BRIEF

published on 06/04/2025 at 13:00, 12 days 9 hours ago

NanoViricides se prépare à une étude animale sur un médicament contre la rougeole

NanoViricides NV-387 Épidémie De Rougeole Déclin Des Vaccins Étude Antivirale
BRIEF

published on 06/04/2025 at 13:00, 12 days 9 hours ago

NanoViricides Prepares for Measles Drug Animal Study

NanoViricides NV-387 Measles Outbreak Vaccine Decline Antiviral Study
PRESS RELEASE

published on 06/04/2025 at 12:55, 12 days 9 hours ago

NanoViricides Measles Drug Development Animal Study is Imminent
NanoViricides, Inc. announces progress in developing a Measles drug, NV-387, a broad-spectrum antiviral with potential to combat Measles outbreaks and vaccine failures

NV-387 NanoViricides Inc. Antiviral Clinical Stage Measles Drug
BRIEF

published on 05/28/2025 at 12:35, 19 days 9 hours ago

NanoViricides to Showcase at Boston's BIO International Convention

NanoViricides Broad-spectrum Antiviral NV-387 Drug BIO Convention 2025 Platform Technologies
BRIEF

published on 05/28/2025 at 12:35, 19 days 9 hours ago

NanoViricides sera présenté à la convention internationale BIO de Boston

NanoViricides Antiviral À Large Spectre Médicament NV-387 Convention BIO 2025 Technologies De Plate-forme
PRESS RELEASE

published on 05/28/2025 at 12:30, 19 days 9 hours ago

NanoViricides to Present at the BIO International Convention in Boston on Monday, June 16, 2025
NanoViricides to present at BIO International Convention 2025 on June 16 in Boston, MA, showcasing breakthrough antiviral drug NV-387 with broad-spectrum efficacy and unique mechanism

NanoViricides NV-387 BIO International Convention Antiviral Drug Clinical Stage
BRIEF

published on 05/22/2025 at 12:35, 25 days 9 hours ago

NanoViricides Comments on New FDA COVID Vaccine Policy

FDA NanoViricides Antiviral Drugs COVID Vaccine Policy Public Health Strategy
BRIEF

published on 05/22/2025 at 12:35, 25 days 9 hours ago

NanoViricides commente la nouvelle politique de la FDA concernant les vaccins contre la COVID-19

FDA NanoViricides Médicaments Antiviraux Politique De Vaccination Contre La COVID Stratégie De Santé Publique
PRESS RELEASE

published on 05/22/2025 at 12:30, 25 days 9 hours ago

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr. Diwan
NanoViricides, Inc. comments on the new COVID Vaccine Booster Shots policy adopted by the US FDA with focus on specific high-risk groups. Dr. Anil Diwan emphasizes evidence-based decision making for vaccine boosters

NanoViricides Inc. COVID Vaccine Booster Shots US FDA Policy Vaccine Effectiveness Dr. Anil Diwan
BRIEF

published on 05/16/2025 at 12:35, 1 month ago

NanoViricides fait progresser l'antiviral NV-387 dans les essais de phase II

Essai De Phase II Mise À Jour Financière Antiviral À Large Spectre Traitement MPox Épidémie De Rougeole

Accesswire

Published on 06/16/2025 at 20:10, 2 hours 17 minutes ago

Gaucho Holdings Emerges from Chapter 11, Aligns with Argentina's Economic Upswing and Investor Confidence
Published on 06/16/2025 at 17:30, 4 hours 57 minutes ago

NexOptic Technology Corp. Provides Default Status Report on Annual Financial Statements
Published on 06/16/2025 at 15:00, 7 hours 27 minutes ago

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
Published on 06/16/2025 at 15:00, 7 hours 27 minutes ago

Aeonian Resources Reports Highly Anomalous Copper Assay Results from Surface Sampling Program at Koocanusa Project, Southeast British Columbia
Published on 06/16/2025 at 14:50, 7 hours 37 minutes ago

1933 Industries Reports Profit in Third Quarter 2025 Financial Results

View all ACCESSWIRE

EQS Group

Published on 06/16/2025 at 22:00, 27 minutes ago

Saudia Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025
Published on 06/16/2025 at 20:04, 2 hours 23 minutes ago

EQS-Adhoc: The Grounds Real Estate Development AG: Management Board negotiating potential takeover of asset management for individual companies of the insolvent Ziegert Group -
Published on 06/16/2025 at 19:50, 2 hours 37 minutes ago

Netfonds AG publishes audited annual financial statements for 2024 / Proposal to increase dividend by 40% to EUR 0.35 per share
Published on 06/16/2025 at 19:40, 2 hours 47 minutes ago

Mukuru Named FXC Intelligence Top 100 Cross-Border Payments Company for Sixth Year
Published on 06/16/2025 at 19:01, 3 hours 26 minutes ago

Mister Spex SE stays on strategic course despite market headwinds: EBIT guidance confirmed, revenue guidance adjusted

Les Echos

Published on 06/16/2025 at 19:09, 3 hours 18 minutes ago

250616 BENETEAU Transactions sur actions propres
Published on 06/16/2025 at 18:00, 4 hours 27 minutes ago

Covivio reprend la pleine propriété de la tour CB21 dans un contexte dynamique pour le marché de Paris-La Défense
Published on 06/16/2025 at 18:00, 4 hours 27 minutes ago

Covivio takes over full ownership of the CB21 tower in a dynamic context for Paris-La Défense market
Published on 06/16/2025 at 18:00, 4 hours 27 minutes ago

Mr.Bricolage lance deux tests sur la distribution de marques propres de Kingfisher et la conversion d’un magasin Mr.Bricolage en franchise Brico Dépôt.
Published on 06/16/2025 at 18:00, 4 hours 27 minutes ago

Mr.Bricolage launches two pilot initiatives: the distribution of Kingfisherowned brands and the conversion of a Mr.Bricolage store into a Brico Dépôt franchise.

View all LES ECHOS COMFI WIRE